BMSG Biomedical Solutions Group

About the Company

BMSG Biomedical Solutions Group (BMSG-Poland) is an independent, private service company operating in the biotechnology sector, registered in Illinois, USA. The company uses the main research facilities of the Jagiellonian University and the Polish Academy of Sciences (PAN) in Krakow, enabling the conduct of advanced projects in the field of medicine and biotechnology. Since the beginning of its activity, BMSG has been among the pioneers of the biotechnology sector in Poland and Central Europe, focusing on the development of applied research and services at the intersection of biomedicine and technology.

Business Scope

BMSG specializes in providing biomedical test services and supplying products from animal tissues, particularly from large transgenic animals. Research services include tests on animal models in the area of immunological, autoimmune, inflammatory diseases, as well as pharmacological and pharmaco-behavioral studies. The company also conducts projects related to cancer diagnostics, including respiratory, gastrointestinal, head and neck, and female reproductive systems, focusing on diagnostic markers for these types of diseases. BMSG uses standard and routinely applied laboratory protocols, which promotes the reproducibility and reliability of research results for scientific and commercial clients.

Products and Services

Biomedical Test Services

The company carries out tests on animal models of immunological and autoimmune diseases, as well as inflammatory states, supporting the development of new therapies and drugs. The offer also includes pharmaco-behavioral studies and pharmacological tests, allowing for the assessment of the efficacy and safety of active substances before their further clinical development.

Laboratory Animals and Tissues

BMSG breeds genetically modified laboratory animals on request and provides large transgenic animals to clients. The range of products includes tissues from transgenic animals, such as pigs, goats, or rabbits, which are used in projects related to xenotransplantation and the production of biological products. The company also offers biological products, such as immunosera, antitoxins, and immunoglobulins, useful in preclinical studies and diagnostic applications.

Clients and Applications

BMSG's offer is primarily aimed at research units, scientific teams, and commercial entities operating in the field of medicine, biotechnology, and drug development. The company's services are used by entities conducting research on immunological diseases, cancers, and other conditions requiring advanced animal models and specialized pharmacological tests. Thanks to the combination of academic infrastructure with experience in the service sector, BMSG supports the development of innovative therapies and diagnostic tools, including projects funded from both public and commercial sources.

Research Cooperation

BMSG cooperates with academic centers and commercial partners, combining scientific competencies with practical needs of the healthcare and biotechnology sectors. The use of Jagiellonian University and PAN infrastructure allows conducting research and development work in specialized laboratories, maintaining high quality and safety standards. Projects carried out by BMSG are supported by various sources of funding, including grants and funds from commercial entities, which facilitates the continuation of work on new solutions in diagnostics and therapy.